{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:04:29Z","timestamp":1791893069228,"version":"4.3.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.xphs.2026.104536","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:57:29Z","timestamp":1791475049000},"page":"104536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Influence of drug loading and lipid dose on the in vivo performance of fenofibrate in medium- and long-chain triglyceride solutions"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4894-7765","authenticated-orcid":false,"given":"Ren\u00e9","family":"Holm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Kusic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9755-053X","authenticated-orcid":false,"given":"Erling B.","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.xphs.2026.104536_bib0001","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ijpharm.2013.03.054","article-title":"Lipid-based formulations for oral administration of poorly water-soluble drugs","volume":"453","author":"Mu","year":"2013","journal-title":"Int J Pharm"},{"issue":"7","key":"10.1016\/j.xphs.2026.104536_bib0002","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.addr.2007.05.006","article-title":"Oral lipid-based formulations","volume":"59","author":"Hauss","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"10.1016\/j.xphs.2026.104536_bib0003","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1111\/j.2042-7158.2010.01107.x","article-title":"New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs","volume":"62","author":"M\u00fcllertz","year":"2010","journal-title":"J Pharm Pharmacol"},{"issue":"3\u20134","key":"10.1016\/j.xphs.2026.104536_bib0004","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejps.2006.04.016","article-title":"Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system","volume":"29","author":"Pouton","year":"2006","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2026.104536_bib0005","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/jps.23359","article-title":"The role of BCS (biopharmaceutics classification system) and BDDCS (biopharmaceutics drug disposition classification system) in drug development","volume":"102","author":"Benet","year":"2013","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2026.104536_bib0006","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejps.2013.04.002","article-title":"Biopharmaceutical classification of poorly soluble drugs with respect to \u201cenabling formulations","volume":"50","author":"Buckley","year":"2013","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2026.104536_bib0007","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.addr.2007.10.014","article-title":"Enhancing intestinal drug solubilisation using lipid-based delivery systems","volume":"60","author":"Porter","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"10.1016\/j.xphs.2026.104536_bib0008","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1021\/mp500545k","article-title":"Kolliphor surfactants affect solubilization and bioavailability of fenofibrate. Studies of in vitro digestion and absorption in rats","volume":"12","author":"Berthelsen","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2026.104536_bib0009","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ejps.2013.09.022","article-title":"Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium","volume":"51","author":"Borkar","year":"2014","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2026.104536_bib0010","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s12272-013-0169-4","article-title":"In vitro and in vivo evaluation of a self-microemulsifying drug delivery system for the poorly soluble drug fenofibrate","volume":"37","author":"Cho","year":"2014","journal-title":"Arch Pharm Res"},{"issue":"2","key":"10.1016\/j.xphs.2026.104536_bib0011","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/jps.23384","article-title":"The effect of administered dose of lipid-based formulations on the in vitro and in vivo performance of cinnarizine as a model poorly water-soluble drug","volume":"102","author":"Lee","year":"2013","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2026.104536_bib0012","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1208\/s12249-012-9787-2","article-title":"Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: effects of digestion","volume":"13","author":"Mohsin","year":"2012","journal-title":"AAPS PharmSciTech"},{"issue":"6","key":"10.1016\/j.xphs.2026.104536_bib0013","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.addr.2007.10.010","article-title":"Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies","volume":"60","author":"Pouton","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"10.1016\/j.xphs.2026.104536_bib0014","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrd2197","article-title":"Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs","volume":"6","author":"Porter","year":"2007","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"10.1016\/j.xphs.2026.104536_bib0015","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1023\/B:PHAM.0000016283.87709.a9","article-title":"Drug solubilization behavior during in vitro digestion of suspension formulations of poorly water-soluble drugs in triglyceride lipids","volume":"21","author":"Kaukonen","year":"2004","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.xphs.2026.104536_bib0016","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1023\/B:PHAM.0000016282.77887.1f","article-title":"Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations","volume":"21","author":"Kaukonen","year":"2004","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.xphs.2026.104536_bib0017","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1211\/0022357021771896","article-title":"Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products","volume":"54","author":"Sek","year":"2002","journal-title":"J Pharm Pharmacol"},{"issue":"5","key":"10.1016\/j.xphs.2026.104536_bib0018","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/jps.20039","article-title":"Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine","volume":"93","author":"Porter","year":"2004","journal-title":"J Pharm Sci"},{"issue":"8","key":"10.1016\/j.xphs.2026.104536_bib0019","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1023\/B:PHAM.0000036914.22132.cc","article-title":"Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation","volume":"21","author":"Porter","year":"2004","journal-title":"Pharm Res"},{"issue":"11","key":"10.1016\/j.xphs.2026.104536_bib0020","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1021\/acs.molpharmaceut.5b00498","article-title":"Elucidating the molecular interactions occurring during drug precipitation of weak bases from lipid-based formulations: a case study with cinnarizine and a long chain self-nanoemulsifying drug delivery system","volume":"12","author":"Sassene","year":"2015","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2026.104536_bib0021","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s11095-015-1829-5","article-title":"The precipitation behavior of poorly water-soluble drugs with an emphasis on the digestion of lipid based formulations","volume":"33","author":"Khan","year":"2016","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.xphs.2026.104536_bib0022","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1208\/s12248-014-9589-4","article-title":"In vitro lipolysis data does not adequately predict the in vivo performance of lipid-based drug delivery systems containing fenofibrate","volume":"16","author":"Thomas","year":"2014","journal-title":"AAPS J"},{"issue":"12","key":"10.1016\/j.xphs.2026.104536_bib0023","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1007\/s11095-013-1038-z","article-title":"Toward the establishment of standardized in vitro tests for lipid-based formulations, part 3: understanding supersaturation versus precipitation potential during the in vitro digestion of type I, II, IIIA, IIIB and IV lipid-based formulations","volume":"30","author":"Williams","year":"2013","journal-title":"Pharm Res"},{"issue":"5","key":"10.1016\/j.xphs.2026.104536_bib0024","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/jps.23054","article-title":"Influence of lipid composition and drug load on the in vitro performance of self-nanoemulsifying drug delivery systems","volume":"101","author":"Thomas","year":"2012","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2026.104536_bib0025","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1177\/0192623309336152","article-title":"Untargeted metabolomic profiling as an evaluative tool of fenofibrate-induced toxicology in Fischer 344 male rats","volume":"37","author":"Ohta","year":"2009","journal-title":"Toxicol Pathol"},{"issue":"4","key":"10.1016\/j.xphs.2026.104536_bib0026","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/0192623309336151","article-title":"Fenofibrate-induced muscular toxicity is associated with a metabolic shift limited to type-1 muscles in rats","volume":"37","author":"Okada","year":"2009","journal-title":"Toxicol Pathol"},{"issue":"3","key":"10.1016\/j.xphs.2026.104536_bib0027","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/0192623311431945","article-title":"The PPAR\u03b1 agonists fenofibrate and CP-778875 cause increased \u03b2-oxidation, leading to oxidative injury in skeletal and cardiac muscle in the rat","volume":"40","author":"Pettersen","year":"2012","journal-title":"Toxicol Pathol"},{"issue":"6","key":"10.1016\/j.xphs.2026.104536_bib0028","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.addr.2007.04.005","article-title":"Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug","volume":"59","author":"Hanafy","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"10.1016\/j.xphs.2026.104536_bib0029","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/ilar.43.4.244","article-title":"Guidelines for the design and statistical analysis of experiments using laboratory animals","volume":"43","author":"Festing","year":"2002","journal-title":"ILAR J"},{"issue":"10","key":"10.1016\/j.xphs.2026.104536_bib0030","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1023\/A:1026451721686","article-title":"Confidence interval criteria for assessment of dose proportionality","volume":"17","author":"Smith","year":"2000","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.xphs.2026.104536_bib0031","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/pst.326","article-title":"Exploratory assessment of dose proportionality: review of current approaches and proposal for a practical criterion","volume":"8","author":"Hummel","year":"2009","journal-title":"Pharm Stat"},{"issue":"4","key":"10.1016\/j.xphs.2026.104536_bib0032","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.ejps.2013.04.036","article-title":"In vitro assessment of drug-free and fenofibrate-containing lipid formulations using dispersion and digestion testing gives detailed insights into the likely fate of formulations in the intestine","volume":"49","author":"Devraj","year":"2013","journal-title":"Eur J Pharm Sci"},{"issue":"10","key":"10.1016\/j.xphs.2026.104536_bib0033","first-page":"3582","article-title":"Design of lipid-based formulations for oral administration of poorly water-soluble drugs: precipitation of drug after dispersion of formulations in aqueous solution","volume":"98","author":"Mohsin","year":"2009","journal-title":"JPharmSci"},{"issue":"1","key":"10.1016\/j.xphs.2026.104536_bib0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2008.03.021","article-title":"Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs","volume":"129","author":"Dahan","year":"2008","journal-title":"J Control Rel"},{"key":"10.1016\/j.xphs.2026.104536_bib0035","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ejpb.2015.04.027","article-title":"Chain length affects pancreatic lipase activity and the extent and pH-time profile of triglyceride lipolysis","volume":"93","author":"Benito-Gallo","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"issue":"9","key":"10.1016\/j.xphs.2026.104536_bib0036","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3390\/pharmaceutics13091349","article-title":"Inclusion of medium-chain triglyceride in lipid-based formulation of cannabidiol facilitates micellar solubilization In vitro, but In Vivo performance remains superior with pure sesame oil vehicle","volume":"13","author":"Feng","year":"2021","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.xphs.2026.104536_bib0037","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/jps.10329","article-title":"Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs","volume":"92","author":"Kossena","year":"2003","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2026.104536_bib0038","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1021\/acs.molpharmaceut.1c00015","article-title":"Digestion of lipid-based formulations not only mediates changes to absorption of poorly soluble drugs due to differences in solubilization but also reflects changes to thermodynamic activity and permeability","volume":"18","author":"Tanaka","year":"2021","journal-title":"Mol Pharm"},{"issue":"Suppl 2","key":"10.1016\/j.xphs.2026.104536_bib0039","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/S0928-0987(00)00167-6","article-title":"Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and \u201cself-microemulsifying\u201d drug delivery systems","volume":"11","author":"Pouton","year":"2000","journal-title":"Eur J Pharm Sci"},{"issue":"10","key":"10.1016\/j.xphs.2026.104536_bib0040","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1007\/s11095-010-0213-8","article-title":"Predicting intestinal precipitation\u2013a case example for a basic BCS class II drug","volume":"27","author":"Carlert","year":"2010","journal-title":"Pharm Res"},{"issue":"10","key":"10.1016\/j.xphs.2026.104536_bib0041","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1021\/acs.molpharmaceut.6b00413","article-title":"In vivo precipitation of poorly soluble drugs from lipid-based drug delivery systems","volume":"13","author":"Sassene","year":"2016","journal-title":"Mol Pharm"},{"issue":"9","key":"10.1016\/j.xphs.2026.104536_bib0042","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1111\/j.1440-1746.2012.07172.x","article-title":"Inhibitory effect of ramosetron on corticotropin releasing factor- and soybean oil-induced delays in gastric emptying in rats","volume":"27","author":"Hirata","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104536_bib0043","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1113\/jphysiol.1975.sp010841","article-title":"The volume and energy content of meals as determinants of gastric emptying","volume":"245","author":"Hunt","year":"1975","journal-title":"J Physiol"},{"issue":"3","key":"10.1016\/j.xphs.2026.104536_bib0044","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrd2468","article-title":"Prodrugs: design and clinical applications","volume":"7","author":"Rautio","year":"2008","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"10.1016\/j.xphs.2026.104536_bib0045","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1002\/jps.22226","article-title":"Precipitation of a poorly soluble model drug during in vitro lipolysis: characterization and dissolution of the precipitate","volume":"99","author":"Sassene","year":"2010","journal-title":"J Pharm Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:29:47Z","timestamp":1791890987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926003862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":45,"alternative-id":["S0022354926003862"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104536","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of drug loading and lipid dose on the in vivo performance of fenofibrate in medium- and long-chain triglyceride solutions","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104536","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Pharmacists Association\u00ae.","name":"copyright","label":"Copyright"}],"article-number":"104536"}}